Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-04-01falseNo description of principal activity44falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 05659267 2024-04-01 2025-03-31 05659267 2023-04-01 2024-03-31 05659267 2025-03-31 05659267 2024-03-31 05659267 c:Director2 2024-04-01 2025-03-31 05659267 c:Director4 2024-04-01 2025-03-31 05659267 d:PlantMachinery 2024-04-01 2025-03-31 05659267 d:PlantMachinery 2025-03-31 05659267 d:PlantMachinery 2024-03-31 05659267 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 05659267 d:FurnitureFittings 2024-04-01 2025-03-31 05659267 d:FurnitureFittings 2025-03-31 05659267 d:FurnitureFittings 2024-03-31 05659267 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 05659267 d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 05659267 d:FreeholdInvestmentProperty 2025-03-31 05659267 d:FreeholdInvestmentProperty 2024-03-31 05659267 d:CurrentFinancialInstruments 2025-03-31 05659267 d:CurrentFinancialInstruments 2024-03-31 05659267 d:Non-currentFinancialInstruments 2025-03-31 05659267 d:Non-currentFinancialInstruments 2024-03-31 05659267 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 05659267 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 05659267 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 05659267 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 05659267 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2025-03-31 05659267 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-03-31 05659267 d:ShareCapital 2025-03-31 05659267 d:ShareCapital 2024-03-31 05659267 d:InvestmentPropertiesRevaluationReserve 2025-03-31 05659267 d:InvestmentPropertiesRevaluationReserve 2024-03-31 05659267 d:RetainedEarningsAccumulatedLosses 2025-03-31 05659267 d:RetainedEarningsAccumulatedLosses 2024-03-31 05659267 c:OrdinaryShareClass1 2024-04-01 2025-03-31 05659267 c:OrdinaryShareClass1 2025-03-31 05659267 c:OrdinaryShareClass1 2024-03-31 05659267 c:OrdinaryShareClass2 2024-04-01 2025-03-31 05659267 c:OrdinaryShareClass2 2025-03-31 05659267 c:OrdinaryShareClass2 2024-03-31 05659267 c:FRS102 2024-04-01 2025-03-31 05659267 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 05659267 c:FullAccounts 2024-04-01 2025-03-31 05659267 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05659267 d:AcceleratedTaxDepreciationDeferredTax 2025-03-31 05659267 d:AcceleratedTaxDepreciationDeferredTax 2024-03-31 05659267 6 2024-04-01 2025-03-31 05659267 e:PoundSterling 2024-04-01 2025-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 05659267










DISS MEDICAL CENTRE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

 
DISS MEDICAL CENTRE LIMITED
REGISTERED NUMBER:05659267

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Fixtures, fittings and equipment
 4 
65,853
4,073

Investment property
 5 
1,520,000
1,520,000

  
1,585,853
1,524,073

Current assets
  

Debtors: amounts falling due within one year
 6 
6,488
11,989

Cash at bank and in hand
  
97,141
131,486

  
103,629
143,475

Creditors: amounts falling due within one year
 7 
(98,348)
(128,852)

Net current assets
  
 
 
5,281
 
 
14,623

Total assets less current liabilities
  
1,591,134
1,538,696

Creditors: amounts falling due after more than one year
 8 
(534,035)
(564,858)

Provisions for liabilities
  

Deferred tax
 10 
(59,925)
(48,064)

  
 
 
(59,925)
 
 
(48,064)

Net assets
  
997,174
925,774


Capital and reserves
  

Called up share capital 
 11 
90
90

Investment property reserve
  
283,776
283,776

Profit and loss account
  
713,308
641,908

  
997,174
925,774


Page 1

 
DISS MEDICAL CENTRE LIMITED
REGISTERED NUMBER:05659267
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Dr N U A Wilde
................................................
Dr A Pantazis
Director
Director


Date: 17 November 2025

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
DISS MEDICAL CENTRE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Diss Medical Centre Limited is a private company limited by shares and incorporated in England and Wales, registration number 05659267. The registered office is The Health Centre, Mount Street, Diss, IP22 4WG.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the histprical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.  
The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.
The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated. 

 
2.2

Going concern

The Directors have considered the Company's position at the time of signing the financial statements.  They have considered future trading expectations, the current financial position of the Company and other factors such as mitigating ongoing costs.  
Based on this, the Directors have concluded that the company will have adequate resources to continue in operational existence for at least twelve months from the date of signing these financial statements and will therefore adopt the going concern basis of accounting in preparing these financial statements.  

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Page 3

 
DISS MEDICAL CENTRE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.4

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.5

Fixtures, fittings and equipment

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures & fittings
-
15% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
DISS MEDICAL CENTRE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.6

Investment property

Investment property is carried at fair value determined annually by the directors and periodically by Chartered Surveyors and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset.  No depreciation is provided.  Changes in fair value are recognised in the Income Statement. 


3.


Employees

The average monthly number of employees, including directors, during the year was 4 (2024 - 4).


4.


Tangible fixed assets





Solar panels
Fixtures & fittings
Total

£
£
£



Cost


At 1 April 2024
-
5,089
5,089


Additions
62,546
-
62,546



At 31 March 2025
62,546
5,089
67,635



Depreciation


At 1 April 2024
-
1,016
1,016


Charge for the year
-
766
766



At 31 March 2025

-
1,782
1,782



Net book value



At 31 March 2025
62,546
3,307
65,853



At 31 March 2024
-
4,073
4,073

Page 5

 
DISS MEDICAL CENTRE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.


Investment property


Freehold investment property

£



Valuation


At 1 April 2024
1,520,000



At 31 March 2025
1,520,000

The property was valued by Christie & Co on 27 July 2024. 



2025
2024
£
£

Revaluation reserves


At 1 April 2024
283,776
(60,620)

Net surplus/(deficit) in movement properties
-
344,396

At 31 March 2025
283,776
283,776





6.


Debtors

2025
2024
£
£


Trade debtors
2,782
7,624

Prepayments and accrued income
3,706
4,365

6,488
11,989


Page 6

 
DISS MEDICAL CENTRE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank loans
34,409
37,994

Corporation tax
6,013
7,846

Accruals and deferred income
57,926
83,012

98,348
128,852


The bank loan is secured against property owned by the company.


8.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loans
534,035
564,858

534,035
564,858



9.


Loans


Analysis of the maturity of loans is given below:


2025
2024
£
£

Amounts falling due within one year

Bank loans
34,409
37,994


34,409
37,994


Amounts falling due 2-5 years

Bank loans
534,035
564,858


534,035
564,858


568,444
602,852


Page 7

 
DISS MEDICAL CENTRE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

10.


Deferred taxation




2025


£






At beginning of year
(48,064)


Charged to profit or loss
(11,861)



At end of year
(59,925)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Accelerated capital allowances
(59,925)
(48,064)

(59,925)
(48,064)


11.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



40 (2024 - 40) Ordinary A shares of £1.00 each
40
40
50 (2024 - 50) Ordinary B shares of £1.00 each
50
50

90

90


 
Page 8